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A B S T R A C T
Exposure to environmental toxins, including hydrocarbon solvents, increases the risk of developing Parkinson's
disease. An emergent hypothesis considers microtubule dysfunction as one of the crucial events in triggering
neuronal degeneration in Parkinson's disease. Here, we used 2,5-hexanedione (2,5-HD), the toxic metabolite of
n-hexane, to analyse the early effects of toxin-induced neurodegeneration on the cytoskeleton in multiple model
systems. In PC12 cells differentiated with nerve growth factor for 5 days, we found that 2,5-HD treatment af-
fected all the cytoskeletal components. Moreover, we observed alterations in microtubule distribution and
stability, in addition to the imbalance of post-translational modifications of α-tubulin. Similar defects were also
found in vivo in 2,5-HD-intoxicated mice. Interestingly, we also found that 2,5-HD exposure induced significant
changes in microtubule stability in human skin fibroblasts obtained from Parkinson's disease patients harbouring
mutations in PRKN gene, whereas it was ineffective in healthy donor fibroblasts, suggesting that the genetic
background may really make the difference in microtubule susceptibility to this environmental Parkinson's
disease-related toxin. In conclusion, by showing the imbalance between dynamic and stable microtubules in
hydrocarbon-induced parkinsonism, our data support the crucial role of microtubule defects in triggering neu-
rodegeneration.
1. Introduction
The central pathological feature of Parkinson's disease (PD), the
second most common neurodegenerative disorder worldwide, is mainly
the selective degeneration of dopaminergic neurons in the Substantia
nigra pars compacta projecting to the Corpus striatum, leading to severe
striatal dopamine deficiency, which results in the typical movement
disorders of parkinsonism [1,2]. For the vast majority of PD cases, the
etiology remains unknown, even though both genetic and environ-
mental factors are likely to be implicated [3,4]. Increasing evidence
shows that parkinsonism can be induced by environmental toxins, such
as pesticides and hydrocarbon solvents [5–7]. In detail, the correlation
between n-hexane exposure and PD onset has been investigated mainly
in humans following occupational exposure. The first case report sug-
gesting that this volatile hydrocarbon might induce signs of parkin-
sonism dates back to 1989 [8]. Additional single case reports, as well as
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cohort and neuropathological studies [9–13], helped build up the hy-
pothesis that hydrocarbon solvents may be involved in the etiopatho-
genesis of PD and might be associated with greater severity of motor
symptoms. Intriguingly, meta-analysis revealed that exposure to pesti-
cides or solvents is a risk factor for PD [14]. The search for a causal link
between solvent exposure and neurodegeneration in PD requires the
development of appropriate animal models. Although prolonged ex-
posure to relatively high levels of certain aliphatic solvents, such as n-
hexane and its toxic metabolite the γ-diketone 2,5-hexanedione (2,5-
HD), causes dose-dependent neurodegeneration with clear prevalence
of damage in the distal part of the nerve known as dying-back neuro-
pathy [15–17], evidence indicates that n-hexane can also induce par-
kinsonism in animals. In detail, Pezzoli and colleagues demonstrated
that n-hexane induces a specific dopamine depletion in rat Corpus
striatum and behavioural defects [18,19]. More recently, Zhang and
colleagues found neurodegeneration of nigrostriatal pathway in 2,5-
HD-intoxicated mice with the loss of both nigral dopaminergic neurons
and striatal dopaminergic terminals, thus supporting the causal effect of
toxic exposure in PD etiology [20].
Given that 2,5-HD is the main toxic metabolite of n-hexane, there
has been great interest in its levels and in the molecular mechanisms
underlying its effects on the central nervous system. Both aging and PD
have been associated with a reduction in the capacity to eliminate n-
hexane, measured by blood and urine levels of its metabolites, an al-
teration which may also play a role in the pathogenesis of PD [21].
Notably, 2,5-HD has not only been detected in the urine and blood of
workers with occupational exposure to n-hexane, but is also found at
low concentrations in the general population [22–25]. Since in non-
exposed persons only a minimal part of 2,5-HD could derive from n-
hexane as an ubiquitous micropollutant, it may also be a product of
intermediate metabolism in the human body [26], an assumption that
makes the study of its molecular effects even more relevant. To date,
the known molecular mechanism of action of 2,5-HD is its reaction with
lysine amino groups of proteins forming pyrrole adducts, which prob-
ably undergo secondary oxidation, resulting in crosslinked proteins
[17,27,28]. Neurofilament (NF) protein polymerization and cross-
linking have been proposed as the cardinal lesion in aliphatic γ-dike-
tone neuropathy, since NF accumulation leads to giant neurofila-
mentous axonal swellings and eventual degeneration in central and
peripheral nervous system, typical of this kind of neuropathy [15,27].
The accumulation of NFs, however, does not appear to explain the onset
of the distal axonal degeneration, which is likely to be a consequence of
axonal transport impairment [29]. In addition, similar patterns of distal
axonal degeneration were found in 2,5-HD neuropathy in wild-type and
transgenic mice that do not express NFs [30]. Other potential targets of
aliphatic and aromatic γ-diketones are microtubule (MT)-associated
proteins [31] and MTs themselves [32].
Interestingly, MTs interact with some of the proteins mutated in PD,
such as α-Synuclein [33], LRRK2 [34] and Parkin [35], and are affected
by the action of PD toxins, such as 1-methyl-4-phenylpyridinium
(MPP+) [36] and rotenone [37]. Besides, due to the specific archi-
tecture of neurons, the functionality and survival of these cells are
particularly dependent on intracellular transport sustained by MTs. The
impairment of MTs might result in accumulation of damaged proteins
and organelles forming the axonal swellings described in several neu-
rodegenerative diseases [38,39]. A crucial regulator of MT functions is
the so called “tubulin code”, which consists in post-translational mod-
ifications (PTMs) of tubulin, together with the expression of different α-
and β-tubulin isotypes [40]. Additionally, neurons are an interesting
case, as they are the only known cell type in which tubulin PTMs are
strongly enriched in most cytosolic MTs and linked to neuronal diseases
[41]. Under this light we investigated the changes in MT system after
2,5-HD treatment in a variety of cell lines, including nerve growth
factor (NGF)-differentiated PC12 cells and human skin fibroblasts ob-
tained from healthy donors and PD patients in addition to C57BL mice,
to unravel the molecular mechanisms responsible for toxin-induced PD
neurodegeneration. Here, we show the early impairment of MT stability
in different models, thus suggesting that MT regulation could represent
an interesting target for developing new and more efficient therapies.
2. Materials and methods
2.1. Maintenance and neural differentiation of PC12 cells
PC12 cells were maintained in RPMI 1640 (EuroClone, Pero, Italy)
containing 10% horse serum (ECS0090D, EuroClone) and 5% fetal
bovine serum (HyClone SH 30066, Thermo Fisher Scientific, Waltham,
MA, USA), supplemented with 2mM L-glutamine (EuroClone), peni-
cillin/streptomycin both 100 μg/ml (EuroClone), at 37 °C in a humidi-
fied atmosphere and 5% CO2. The medium was changed every 3–4 days.
Cells were plated at 1.5× 104/cm2 onto poly-L-lysine (Sigma-Aldrich,
St. Louis, MO)-coated cover glass in 35 mm petri dishes for immuno-
fluorescence microscopy or directly onto poly-L-lysine-coated petri
dishes for biochemical analysis. For neural differentiation, the cells
were exposed to 50 ng/ml human β-NGF (PeproTeck, London, UK) in
low serum medium (RPMI 1640 supplemented with 2% horse serum,
2mM L-glutamine, penicillin/streptomycin). The differentiation
medium was changed every 2–3 days with the fresh one. The PC12 cells
were exposed to 2,5-HD (Sigma-Aldrich) at different concentrations
after 5 days of differentiation with human β-NGF and analysed at dif-
ferent time points.
2.2. Ethic statement, generation and maintenance of human fibroblast cell
lines
Primary fibroblasts were obtained by skin biopsies from 6 in-
dividuals. They included 3 healthy subjects as control group and 3
patients affected by PD, harbouring mutations in PRKN gene, whose
characteristics are summarized in Table 2. All patients were examined
by movement disorder neurologists and clinical diagnosis of PD was
established according to the UK Parkinson Disease Society Brain Bank
criteria [42]. The mutations on the PRKN gene were screened as pre-
viously described [43]. The study was approved by the local ethics
committee (Istituti Clinici di Perfezionamento, July 13th 2010) and all
participants gave written informed consent. Human fibroblasts were
cultured in RPMI 1640 containing 15% foetal bovine serum (HyClone)
supplemented with 2mM L-glutamine, penicillin/streptomycin both
100 μg/ml (all from EuroClone) and 50 μM β-mercaptoethanol (Sigma-
Aldrich), at 37 °C in a humidified atmosphere and 5% CO2. For 2,5-HD
treatment, fibroblasts were plated at the density of 1.2× 104/cm2 on
uncoated 35mm petri dishes; the day after, the cells were incubated for
24 h with different concentrations of 2,5-HD (Sigma-Aldrich), and then
analysed. For the cell viability assay, the fibroblasts were grown with
normal medium, which was changed just before the experiments with
fresh medium containing a lower fetal bovine serum concentration
(7.5% instead of 15%) and without β-mercaptoethanol, since both
could interfere with MTT test.
2.3. 2,5-Hexanedione treatments on cells
Five-day NGF-differentiated PC12 cells were incubated for 24, 48 or
72 h with the following concentrations of 2,5-HD: 0.2 mM, 2mM and
20mM. Human fibroblasts were exposed to the same concentrations of
2,5-HD for 24 h. The 2,5-HD was diluted in the fresh appropriate cul-
ture medium and filtered. To start the treatment, the medium was
changed with the one containing 2,5-HD and the cells were incubated
in standard conditions. Once the incubations had finished, the living
cells were observed by phase contrast microscopy and random images
were captured for morphometric analyses. Immediately after, the cells
were fixed with 4% paraformaldehyde (PFA) in phosphate-buffered
saline (PBS, 20mM Na-phosphate, 150mM NaCl, pH 7.2) or cold me-
thanol for immunofluorescence, lysed with cell lysis buffer for Western
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blot analyses, or used for specific tests, such as cell viability or reactive
oxygen species (ROS) production assays.
2.4. Morphometric analysis
The cell morphology of living cells at the end of treatment was
evaluated by phase contrast microscopy. Five random images per well
were captured at 20× magnification from at least 4 different wells per
condition using Axiovert S100 microscope (Zeiss, Oberkochen,
Germany) equipped with AxiocamHR (Zeiss) and then analysed using
Axiovision Release 4.8 software (Zeiss). At least 400 differentiated cells
per condition were considered for PC12 cells, while about 80 cells per
condition and at least 20 per individual were analysed for human fi-
broblasts. For PC12, three principal features of neuritogenesis were
considered: the percentage of differentiated cells, the length of the
longest neurite for each differentiated cell and the percentage of dif-
ferentiated cells presenting varicosities on their longest neurite. A cell
was considered to have differentiated when its longest neurite was at
least twice as long as its cell body diameter [44]. Regarding human
fibroblasts, the maximum and the minimum axes, their ratio and the
cell area were measured.
2.5. Cell viability assay
Cells, previously treated with different concentrations of 2,5-HD,
were incubated with a freshly prepared solution (0.5 mg/ml) of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide salt (MTT,
Sigma-Aldrich). After 3 h of incubation at 37 °C, a solution of 0.1M HCl
in isopropanol was added to each well in equal volume. The intensity of
purple colour of formazan crystals in each well was measured through a
plate-reader spectrophotometer (Infinite 200Pro, Tecan, Mannedorf,
Switzerland) at wavelength of 570 nm.
2.6. DCFDA assay
ROS production was detected using 2′,7′-dichlorofluorescin diace-
tate (DCFDA) Cellular ROS Detection Assay Kit (Abcam, Cambridge,
UK) according to manufacturer's instructions. Briefly, NGF-differ-
entiated PC12 cells were grown in a black multiwell and after 5 days of
differentiation were incubated for 45min with 25 μM DCFDA at 37 °C.
After incubation, the cells were washed once with the kit buffer and
then treated with 2,5-HD for 24 h. Tert-butyl hydrogen peroxide (TBHP,
50 μM for 3 h) that mimics ROS activity was used as positive control.
The fluorescence intensity was finally measured through a plate-reader
spectrophotometer (Infinite 200Pro, Tecan) using the excitation/emis-
sion wavelength 485 nm/535 nm.
2.7. Analysis of mitochondrial network morphology
For staining the active mitochondria MitoTracker Red CMX-Ros
(M7512, Thermo Fisher Scientific) was used according to manufac-
turer's protocol. Briefly, NGF-differentiated PC12 cells treated with 2,5-
HD for 24 h were incubated for 40min with 500 nM MitoTracker Red
CMX-Ros and fixed for 10min with 4% PFA in PBS. The samples were
also counterstained with DAPI to visualize the nuclei and mounted in
Mowiol (Calbiochem, San Diego, CA)-DABCO (Sigma-Aldrich). The
mitochondrial network morphology was investigated only in the soma
of PC12 cells by confocal microscopy performed on a Leica TCS SP5
confocal laser scanning microscope (Leica Microsystems, Heidelberg,
Germany). The images were acquired using LAS AF software (Leica)
with an HCX PL APO 63X/1.4NA oil immersion objective and 405 nm
and 561 nm laser lines. By means of ImageJ software (NIH, Bethesda,
USA), each isolated soma was cropped out from the raw images. The
resulting regions of interest (ROI) were then binarized after the appli-
cation of an intensity-based threshold. The outlines of the network were
then selected and mitochondrial area and perimeter were measured.
The form factor was calculated (defined as [Pm 2]/[4πAm]), where Pm is
the length of the mitochondrial perimeter and Am is the area of the
mitochondria [45]. The form factor allows quantifying the degree of
branching of the mitochondrial network. At least 15 randomly dis-
tributed fields were acquired for each experimental condition and at
least 50 cells for condition were analysed.
2.8. Western blot analysis
Whole cell extracts, Triton X-100 (Sigma-Aldrich)-soluble and -in-
soluble fractions of PC12 cells and human fibroblasts were prepared
and analysed as previously reported [46]. After SDS-PAGE, proteins
were transferred onto polyvinylidene difluoride membrane (Im-
mobilon-FL IPLL00010; Millipore, Darmstadt, Germany) and incubated
overnight at 4 °C with the following primary antibodies: anti-actin
mouse IgM (N350, Amersham, Little Chalfont, UK) 1:4000; anti- neu-
rofilament light protein (NF-L) rabbit IgG (AB-10685, Immunological
Sciences, Rome, Italy) 1:40000, anti- neurofilament medium protein
(NF-M) mouse IgG (MAB-10338, Immunological Sciences) 1:40000,
anti-α-tubulin mouse IgG (clone B-5-1-2, T6074, Sigma-Aldrich)
1:1000; anti-detyrosinated tubulin rabbit IgG (ab 48389, Abcam)
1:1000; anti-tyrosinated tubulin mouse IgG (clone TUB-1A2, Sigma-
Aldrich) 1:1000; anti-acetylated tubulin mouse IgG (clone 6-11B-1,
T7451, Sigma-Aldrich) 1:2000; anti-dynamin-related protein 1 rabbit
IgG (clone D6C7, #8570, Cell Signaling, Danvers, MA, USA) 1:1000;
anti-mitofusin-2 rabbit IgG (clone D2D10, #9482, Cell Signaling)
1:1000; anti-voltage-dependent anion channel 1 (VDAC) rabbit IgG
(ab15895, Abcam) 1:500; anti-microtubule-associated protein 1 light
chain 3 (LC3) rabbit IgG (L8918, Sigma) 1:2000; anti-HRP-glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) mouse IgG2b (mAbcam
9484, Abcam) 1:3000. Membranes were washed for 30min with 3
changes and incubated for 1 h at room temperature with horseradish
peroxidase (HRP) goat anti-mouse IgG (31430, Pierce) 1:20000, HRP
goat anti-rabbit IgG (31460, Pierce) 1:40000 or HRP goat anti-mouse
IgM (ab5930, Abcam) 1:5000. For LC3 we used as secondary antibodies
Alexa Fluor 488 goat anti-rabbit (ab150077, Abcam) 1:4000. The re-
action was developed using a chemiluminescent immunoassay (Super-
Signal West Pico Chemiluminescent, Pierce). To ensure equal protein
loading for the whole protein lysates (not for Triton-soluble/insoluble
fractions), protein samples were assayed by densitometry of Coomassie
blue-stained PVDF membranes and adjusted for blotting. Immunoblots
were scanned with Epson WP-4525 colour image scanner (Seiko Epson
Corporation, Suwa, Japan) and their quantitation was performed by
ImageJ software. For LC3 and GAPDH acquisition and quantification
were performed by Chemidoc and Image Lab software (Bio-Rad, Her-
cules, CA, USA).
2.9. Immunofluorescence and labeling on PC12 cells
Cells were fixed with methanol at−20 °C or 4% PFA for 10min and
incubated with the following primary antibodies, previously used for
immunoblotting, and probes: Atto 565 Phalloidin (94072, Sigma-
Aldrich) 1:100; NF-L rabbit IgG 1:1000; α-tubulin mouse IgG 1:500;
detyrosinated tubulin rabbit IgG 1:100; tyrosinated tubulin mouse IgG
1:100; acetylated tubulin mouse IgG 1:100; and 4′,6-Diamidino-2-phe-
nylindole dihydrochloride DAPI (D-8417, Sigma-Aldrich) 1:40000. As
secondary antibodies we used: Alexa Fluor 568 goat anti-mouse
(A11004, Thermo Fisher Scientific) 1:1000; Alexa Fluor 488 goat anti-
rabbit (ab150077, Abcam) 1:1000. The coverslips were mounted in
Mowiol-DABCO and samples were examined with the Axiovert 200M
microscope (Zeiss). Furthermore, the cells showing a perinuclear ac-
cumulation of detyrosinated MTs were counted and the percentage
respect to the total number of differentiated cells was calculated for
each experimental condition. At least 15 randomly distributed fields
were acquired for each experimental condition and at least 770 cells for
condition were analysed.
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2.10. Tubulin assembly in vitro
Tubulin was purified from fresh bovine brain conserved in ice-cold
PBS. Pure tubulin was obtained by two cycles of polymerization-de-
polymerization in a high-molarity buffer [47] resuspended in BRB80
(80mM K-Pipes pH 6.9, 2 mM EGTA, 1mM MgCl2; all from Sigma-Al-
drich), snap-frozen in liquid nitrogen, and stored in small aliquots at
−80 °C. The kinetics of tubulin polymerization was studied using a
standard protocol [48] in the absence or presence of different con-
centration of 2,5-HD. Reactions were followed turbidimetrically at
350 nm for 90min at 37 °C in a multimode plate reader (Infinite
200Pro, Tecan) equipped with a temperature controller. Pure bovine
brain tubulin was diluted in a previously degassed assembly buffer
(80mM K-Pipes, pH 6.9, 2 mM EGTA, 1mM MgCl2, 10% glycerol, and
1mM GTP) to the working concentration of 30 μM and kept on ice; the
reaction was started by heating up the solution to 37 °C. Polymerization
time-course was dissected in order to calculate the kinetic parameters
describing the different phases of the process as previously reported
[48]. The number of successive steps in the nucleation (P) was de-
termined by plotting log(A(t)/A∞) against log(t). The maximal velocity
of polymerization (Vi) was calculated as the variation of mass versus
time (δA/δt) at the very initial elongation phase, whereas total extent of
MT assembly was deduced from the total absorbance variation (ΔA)
achieved as the steady-state was established.
2.11. Electron microscopy
Negative staining of pure tubulin was prepared by leaving a drop of
assembled MTs, previously fixed with 1% (v/v) glutaraldehyde, on
Formvar Carbon Film-coated 200 square mesh Nickel grids (FCF200-Ni-
50, Electron Microscopy Sciences, Hatfield, PA, USA) for 30min at
25 °C. The grids were first washed three times with 5mM EGTA, then
dipped rapidly twice in 1% uranyl acetate and let dry on filter paper at
room temperature. The transmission electron microscopy images were
obtained with a Zeiss LEO 912AB Energy Filtering TEM operating at
80 kV. Digital images were acquired using a CCD-BM/1K camera op-
erating with iTEM software (Olympus).
2.12. Animals
All mice were kept in pathogen-free conditions and all procedures
complied with the Italian law D.lgs 116/92 and were approved by the
University of Milan Animal Welfare Body and by Italian Ministry of
Health (protocol number 6/2012). Wild-type C57BL mice were pur-
chased from Charles River (Calco, Italy) and used for all experiments.
Mice were kept under environmentally controlled conditions (ambient
temperature 22 °C; humidity 40%) on a 12-hour light/dark cycle with
food and water ad libitum.
2.13. 2,5-Hexanedione treatments on animals
Fifteen-month old mice were treated with intraperitoneal injections
of 2,5-HD 8mmol/kg for 19 consecutive days, as previously reported
[30]. Control mice were injected with saline. Twenty-four hours after
last injection of 2,5-HD, mice were sacrificed in order to fix and process
the brains for immunohistochemical and immunofluorescence analyses.
Mice were deeply anesthetized and transcardially perfused with 4%
PFA in 0.1M phosphate buffer pH 7.4 as previously described [49].
Brains were removed, postfixed 3 h in 4% PFA and then cut with a
vibratome (VT1000S; Leica) in both coronal and sagittal sections
(50 μm thick) to be used for immunohistochemical and immuno-
fluorescence stainings, respectively. Part of the sections was cryopro-
tected for long-term conservation at −20 °C.
2.14. Immunohistochemistry of tyrosine hydroxylase with
diaminobenzidine
Free-floating coronal sections (50 μm thick) were selected at dif-
ferent rostro-caudal levels of Substantia nigra pars compacta or Corpus
striatum and were immunolabeled with an antibody against tyrosine
hydroxylase (TH) according to a standard immunoperoxidase protocol.
Briefly, the selected sections were incubated overnight at 4 °C with the
primary antibody anti-TH rabbit IgG (1:200; Millipore) and then in-
cubated with biotin-labeled goat anti-rabbit IgG antibody (1:200;
Vector Laboratories, Inc., Burlingame, CA, USA) for 75min.
Immunoreactivities were visualized by avidin-biotin HRP complex
(ABC Elite; Vector Laboratories) using the chromogen 3,3′-diamino-
benzidine tetra-hydrochloride (DAB, Roth, Karlsruhe, Germany) for
detection.
2.15. Stereological counts of tyrosine hydroxylase-positive neurons in
Substantia nigra pars compacta
To estimate the total number of TH-positive cells in the entire
Substantia nigra pars compacta, we performed stereological cell count-
ings using the optical fractionator method on workstation with the
stereological software StereoInvestigator7 (MicroBright-Field Inc.,
Colchester, Vermont, USA) connected to a Leica DMLB microscope
equipped with a motorized stage and coupled to a Retiga 2000R colour
uncooled camera. The stereological analysis was performed on 7 cor-
onal sections of 50 μm per animal, sampled every 150 μm, in which the
Substantia nigra pars compacta was identified and outlined at 4× mag-
nification, while the counts of TH-positive cells were conducted at 40×
magnification. For stereological counting, we used a grid of dissectors
(counting frame 50× 50 μm; grid size 100×100 μm) and the final
analysed section thickness was about 26 μm in the Z-axis. The TH-po-
sitive cells were counted only as they came into focus within the
counting frame area and also if touching or crossing the inclusion lines.
The estimated total number of TH-positive cells in the Substantia nigra
pars compacta was computed from the formula: N= ∑(n)× 1/SSF×1/
ASF×1/TSF, where n is the total number of TH-positive cells counted
on each dissector; SSF (section sampling fraction) is the number of
regularly spaced sections used for counts divided by the total number of
sections across the Substantia nigra pars compacta; ASF (area sampling
fraction) is the total area of all dissectors divided by the total area of all
the regions drawn on the sections (2500 μm2×dissector number/total
area of all regions to be counted); and TSF (thickness sampling fraction)
is the dissector thickness (26 μm) divided by the section thickness
(50 μm). The precision of the estimate of total number of TH-positive
cells in each subject was evaluated as the coefficient of error and the
sampling was considered optimal when this was< 0.05.
2.16. Densitometric analysis of tyrosine hydroxylase-positive axonal
terminals in Corpus striatum
For the densitometric analysis, 2 coronal sections per animal were
collected from the Corpus striatum between +1.08mm and +0.14mm
according to bregma in the mouse brain atlas [50]. Densitometric
analysis of TH-positive axonal terminals in Corpus striatum was per-
formed using ImageJ software measuring the optical density (O.D.). The
selected coronal sections were acquired with a Leica DMLB microscope
coupled to a Retiga 2000R colour uncooled camera using a 2.5× ob-
jective. Once done the O.D. calibration in ImageJ to convert the grey
scale values in O.D. values, the following ROIs were identified and
outlined for each section: the total striatum, the dorsal striatum and the
dorso-lateral striatum. The mean O.D. values were measured for all the
regions. The background value for each section was measured in the
Corpus callosum and was then subtracted from the mean values mea-
sured in all the ROIs of the Corpus striatum. Subsequently, the mean
value of two sections per animal was calculated before the data were
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processed statistically.
2.17. Immunofluorescent staining, confocal microscopy and image analysis
For the immunofluorescence analysis, 2 sagittal sections per animal,
containing the entire nigrostriatal pathway, were collected. Selected
free-floating sections were incubated overnight at 4 °C with the fol-
lowing primary antibodies: anti-tyrosinated tubulin rat IgG (clone YL 1/
2; Abcam) 1:100; anti-detyrosinated tubulin rabbit IgG 1:500, and anti-
acetylated tubulin mouse IgG 1:500. To identify the dopaminergic
neuronal structures (soma, fibers and terminals), each section was
concurrently stained with anti-TH antibody made in mice (clone LCN1;
Millipore) 1:200 or rabbits 1:200 as appropriate. After several rinses in
PBS, the sections were incubated in the following secondary antibodies:
Alexa Fluor 488 goat anti-mouse IgG, Alexa Fluor 488 goat anti-rabbit
IgG, Alexa Fluor 568 donkey anti-mouse IgG, Alexa Fluor 568 donkey
anti-rabbit IgG and Alexa Fluor 568 donkey anti-rat IgG (Thermo Fisher
Scientific). Just the section in Fig. 7A, showing an overview of the ni-
grostriatal pathway, was also counterstained with DAPI (1:4000) for
15min before the mounting step. Finally, the samples were mounted in
PBS-glycerol. Confocal microscopy was performed on these samples
with a Leica TCS SP5 confocal laser scanning based on a Leica DMI
6000B inverted microscope. The images were acquired with a HCX PL
APO 40X/1.25NA oil immersion objective using 488 nm and 561 nm
laser lines. The software used for all acquisitions was Leica LAS AF.
Once the parameters of acquisition for control conditions had been
defined, they were kept constant for all the samples. Images were ac-
quired in three different brain regions: Substantia nigra pars compacta,
the nigrostriatal fibers' region and the dorsal part of Corpus striatum.
Quantification of the mean fluorescence intensity inside dopaminergic
neurons was performed using ImageJ software. For the region of Sub-
stantia nigra pars compacta, only somas in which the nucleus was clearly
evident have been selected for the analysis and the perimeter was
manually drawn excluding the area occupied by the nucleus from each
cell area. The ROIs were drawn using the TH channel and subsequently
applied on the channel of the selected α-tubulin PTM. Similarly, for
nigrostriatal fibers and Corpus striatum regions, a mask was created
using an appropriate threshold for every image on the TH channel and
then applied onto the channel of the selected α-tubulin PTM.
2.18. Statistical analyses
Data from two experimental groups were analysed by paired/un-
paired Student's t-test and the normal distribution of experimental data
was previously assessed with the Kolmogorov-Smirnov test, using the
Prism 8 (GraphPad Software, Inc.) software. In the case of more than
two experimental groups, statistical analyses were performed by one-
way analysis of variance (ANOVA) followed by Tukey HSD, Fisher LSD
or Dunnett 2-sided test as post hoc multiple comparison test using
STATISTICA7 software (StatSoft Inc., Tulsa, OK). When the distribution
was not normal, data were analysed using the non-parametric Mann-
Whitney U or Kruskal-Wallis test for the comparison between two or
more groups, respectively. Finally, χ2 test was used to analyse quali-
tative variables, as appropriate. Data are expressed as means± SEM.
All experiments were repeated at least three times. p < 0.05 was
considered statistically significant.
3. Results
3.1. 2,5-Hexanedione induces morphological changes in NGF-differentiated
PC12 cells
We started our investigation about the effects of 2,5-HD on NGF-
differentiated PC12 cell line, as it is a well-characterized model of
cultured dopaminergic neurons [51], which are the neurons that are
selectively lost in PD. In order to set up the PD toxin assays, the opti-
misation of the exposure time was carried out by treating 5-day NGF-
differentiated PC12 cells with different concentrations of 2,5-HD (0.2,
2, 20mM) for 24, 48, and 72 h (Fig. 1). Firstly, the toxin effect on cell
viability was examined by MTT test, showing that cell survival was
significantly reduced only at the highest concentration of 2,5-HD after
48 and 72 h, but not after 24 h (Fig. 1B). In parallel, the observation of
living cells by phase contrast technique revealed some morphological
alterations of the treated cells (Fig. 1A). In order to quantify these
changes, morphometric analyses were performed to evaluate the per-
centage of differentiated cells (Fig. 1C), the neurite length of differ-
entiated cells (Fig. 1D) and the percentage of neurites with axonal
swellings, called varicosities (Fig. 1E). According to these analyses, 2,5-
HD induced the shortening of neurite length with consequent reduction
in differentiated phenotype after 48 and 72 h (Fig. 1C–D). Moreover,
2,5-HD was also able to induce the formation of varicosities along
neurites already at 2mM after 24 h of treatment (Fig. 1E). Based on
these observations, we conclude that 2,5-HD affects cell morphology in
NGF-differentiated PC12 cells leading to major alterations over time.
Taking into account that cell viability was not yet affected within the
first 24 h of toxin exposure, this administration scheme was applied as a
good experimental paradigm to investigate the early events of neuro-
degeneration in subsequent experiments.
3.2. Mitochondria are altered by high doses of 2,5-hexanedione
Since the most common PD toxins, such as MPP+ or rotenone, are
potent inhibitors of complex I of the electron transport chain, mi-
tochondrial dysfunction has been considered one of the principal cul-
prits of neuronal death in PD, together with oxidative stress and protein
degradation inefficiency, for a long time [52]. To verify this hypothesis,
we looked at the impact of 24 hour-treatment with 2,5-HD on oxidative
stress and mitochondrial dynamics (Fig. 2) in the same conditions in
which we had already observed alterations in cell morphology. In order
to quantify ROS production, the DCFDA assay was performed, revealing
that a significant increase in ROS was induced only by the highest
concentration (20mM) (Fig. 2A). Moreover, the levels of dynamin-re-
lated protein 1 and mitofusin 2, two crucial proteins regulating mi-
tochondrial fission and fusion respectively [53], were investigated by
Western blot analysis. Both protein levels were decreased only at the
highest dose of toxin (Fig. 2B–C). Finally, in order to analyse the mi-
tochondrial network morphology, we evaluated the degree of mi-
tochondrial branching. Notably, the network was altered following in-
cubation with 20mM 2,5-HD (Fig. 2D–E) and the significant decreased
of branching was revealed by the analysis of the form factor value
(Fig. 2F). Interestingly, 2,5-HD strongly affects neuronal morphology
already at 2mM, whereas mitochondrial defects are detectable only at
20mM, allowing us to speculate that they could be a possible
Fig. 1. 2,5-Hexanedione induces morphological changes in NGF-differentiated PC12 cells.
(A) Representative phase contrast images of 5-day NGF-differentiated PC12 cells treated with different concentrations of 2,5-HD. Scale bar: 50 μm. (B) Cell viability,
evaluated by MTT assay, was affected only at 20mM after 48 and 72 h of exposure. #p < 0.01 vs control (CTRL) according to one-way ANOVA, Dunnett post hoc
test. (C–E) Morphometric analyses revealed significant morphological alterations induced by 2,5-HD in a dose-dependent manner. Three principal features of
neuritogenesis were considered: the percentage of differentiated cells (histogram, C), the length of the longest neurite for each differentiated cell (box plot, D) and the
percentage of differentiated cells presenting varicosities on their longest neurite (histogram, E). 2,5-HD treatment induced the shortening of neurites' length with
consequent reduction in differentiated state of the cells and induced the formation of small axonal swelling. All values are expressed as mean ± SEM. For the
percentage of neuronal differentiation (C) and neurites with varicosities (E) #p < 0.01 and **p < 0.001 vs CTRL according to χ2 test. For the neurite length (D)
*p < 0.05 and **p < 0.001 vs CTRL according to one-way ANOVA, Dunnett post hoc test.
F.V.M. Casagrande, et al. BBA - Molecular Basis of Disease 1866 (2020) 165581
6
consequence of the impairment of other frailer systems.
3.3. 2,5-Hexanedione impacts on all the components of the cytoskeleton in
NGF-differentiated PC12 cells
In accordance with previous works suggesting that 2,5-HD affects
cytoskeletal components [28], we hypothesized that the observed
morphological changes probably derived from dysfunction of the
overall cytoskeleton. Thus, the characterization of all its components
(actin filaments, NFs and MTs) after 24 h of toxin treatment was carried
out with both biochemical and immunocytochemical approaches
(Fig. 3). The Western blot and its densitometric analysis (Fig. 3A–B)
revealed a significant decrease in the levels of both NF-L and NF-M at
the highest concentration, while the overall content of α-tubulin and
actin remained unchanged. In parallel, immunofluorescence stainings
were performed to investigate distribution and organization of the three
cytoskeletal filaments in detail (Fig. 3C). Actin showed a particular
organization in bundle-like structures at 2mM of 2,5-HD. Interestingly,
this kind of rearrangement of microfilaments into ruffles has been de-
scribed also in epithelial cells [54]. As expected and already described
in the literature in other neuron-like cellular models [55,56], NF-L
(Fig. 3C), as well as NF-M (data not shown), collapsed into varicosities
and in the perinuclear zone in a dose-dependent manner. The α-tubulin
staining, instead, highlighted marked dose-dependent fragmentation of
the MT cytoskeleton along neurites and also an unusual perinuclear
accumulation (Fig. 3C). These data revealed that 2,5-HD impacts all the
cytoskeletal components in NGF-differentiated PC12 cells and, to the
best of our knowledge, these results show for the first time the loss of
integrity of MTs following 2,5-HD treatment, which could likely lead to
the impairment of axonal transport and, consequently, to the accumu-
lation of NFs since they are transported along axons in a MT-dependent
manner [57].
3.4. 2,5-Hexanedione causes the imbalance of α-tubulin PTMs, changing
microtubule distribution and stability in NGF-differentiated PC12 cells
The above reported results strongly suggest that the MT cytoske-
leton is a relevant target of 2,5-HD and plays a key role in PD-related
neurodegenerative processes. To verify this hypothesis we carried out a
more in-depth investigation of MTs through the analysis of different α-
tubulin PTMs (Fig. 4) that specifically correlate with subsets of MTs
characterized by different stability [58]. Surprisingly, unlike the overall
amount of α-tubulin, which was not significantly changed (Fig. 3A–B),
the biochemical approach showed significant differences in PTM levels
at 20 mM of 2,5-HD (Fig. 4A–B). In fact, the Western blot analysis re-
vealed a significant increase in the level of detyrosinated tubulin,
marker of stable MTs, and a concurrent decrease in the level of tyr-
osinated tubulin, associated to dynamic MTs (Fig. 4A–B). The alteration
in stable MTs was also highlighted by immunofluorescence staining,
which revealed perinuclear accumulation of both detyrosinated and
acetylated tubulin, as well as their fragmentation, at the highest dose of
2,5-HD (Fig. 4C). We calculated the percentage of differentiated cells
that exhibits the perinuclear accumulation of detyrosinated tubulin and
we found a significant increase already at 0.2mM 2,5-HD (Fig. 4D).
Fig. 2. Mitochondria are altered by high doses of 2,5-hexanedione.
(A) Reactive oxygen species (ROS) production was measured using DCFDA Cellular ROS Detection assay on 5-day NGF-differentiated PC12 cells treated for 24 h with
different concentrations of 2,5-HD. Tert-butyl hydrogen peroxide (TBHP, 50 μM for 3 h), which mimics ROS activity, was used as positive control. The data are
expressed as fold change with respect to control (mean ± SEM). *p < 0.05 vs control according to one-way ANOVA, Fisher LSD post hoc test. (B) Immunoblot and
(C) densitometric analyses of dynamin-related protein 1 (DRP1) and mitofusin-2 (MFN2) were performed in whole cell extracts from 5-day NGF-differentiated PC12
cells treated for 24 h with different concentrations of 2,5-HD. For the quantitation, values of each mitochondrial protein were normalized on the level of mi-
tochondrial porin (VDAC) of the relative sample. All values are expressed as mean ± SEM. The data are expressed as fold change with respect to control
(mean ± SEM). #p < 0.01 vs control according to one-way ANOVA, Fisher LSD post hoc test. (D) Representative images of the mitochondrial network labeled with
MitoTracker Red CMX-Ros in soma of NGF-differentiated PC12 cells after 24-hour treatment with 2,5-HD. Scale bar: 5 μm. (E) Corresponding binarized masks used to
estimate the degree of mitochondrial branching (form factor). (F) Box plot displaying the form factor values obtained for the analysis of mitochondrial network
morphology. The form factor value was significantly decreased only at 20mM respect to control. *p < 0.05 vs CTRL according to Kruskal-Wallis test, at least 50 cells
for each group were analysed.
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Furthermore, in order to verify whether the observed intracellular ac-
cumulation was correlated with the activation of the autophagic
pathway, we checked for the levels of LC3-I and -II, well known marker
of autophagy. We observed no significant changes induced by 2,5-HD in
LC3-I (Fig. S1A–B), whereas the LC3-II protein levels were too low to be
quantified (Fig. S1C). Indeed, we did not detect any conversion of LC3-I
to LC3-II which is a reliable indicator of autophagic activity (Fig. S1).
The abnormal organization of stable MTs may be evidence of greater
changes in the MT system, which can cause the impairment of axonal
transport, with consequent accumulation of proteins and organelles
[39], such as the accumulation of NFs in the cell body we showed in
Fig. 3C. These results also offer an explanation for the neurite retraction
and the reduction of neuronal phenotype caused by 2,5-HD exposure
longer than 24 h in NGF-differentiated PC12 cells (Fig. 1C–D).
To further investigate the effect of the toxin on MT stability, we
studied the ratio between the free and polymerized form of in cell α-
tubulin and the in vitro kinetics of tubulin assembly in the presence of
2,5-HD (Fig. 5). In order to study the state of in cell tubulin assembly
(Fig. 5A–B), we analysed the tubulin fractions composed by free dimers
with respect to polymerized MTs. The highest toxin concentration of
2,5-HD caused the shift of tyrosinated tubulin towards the dimer pool,
suggesting depolymerization of MT system and consequent decrease in
MT stability. Moving to the in vitro assay, we analysed the assembly
kinetics of pure tubulin in the presence of increasing concentrations of
2,5-HD (Fig. 5C) and calculated the following parameters (Table 1): P
value for nucleation phase, the initial velocity of polymerization (Vi)
and the final absorbance at 350 nm (ΔA). No significant changes in the
assembly curves and in the parameters defining the different phases
Fig. 3. 2,5-Hexanedione impacts on all the components of the cytoskeleton in NGF-differentiated PC12 cells.
(A) Immunoblot and (B) densitometric analyses of actin (Actin), neurofilament light protein (NF-L), neurofilament medium protein (NF-M) and α-tubulin (α-Tub)
were performed in whole cell extracts from 5-day NGF-differentiated PC12 cells treated for 24 h with different concentrations of 2,5-HD. For the quantitation, values
of each protein were normalized on the total amount of proteins loaded per lane, through the Coomassie blue staining. The data are expressed as fold change with
respect to control (mean ± SEM). *p < 0.05 vs control (CTRL) according to one-way ANOVA, Fisher LSD post hoc test. (C) NGF-differentiated PC12 cells were
stained with Atto565-conjugated phalloidin or with primary anti-NF-L and anti-α-tubulin antibodies to reveal the organization of actin fibers (Actin, top), neuro-
filaments (NF-L, middle) and microtubules (α-Tub, bottom), respectively, and acquired with a widefield fluorescence microscope. Scale bar: 20 μm.
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Fig. 4. 2,5-Hexanedione causes the imbalance of α-tubulin PTMs in NGF-differentiated PC12 cells.
(A) Immunoblot and (B) densitometric analyses of post-translational modifications (PTMs) of α-tubulin (α-Tub): tyrosinated tubulin (Tyr Tub), detyrosinated tubulin
(deTyr Tub) and acetylated tubulin (Ac Tub). The analyses were performed on whole cell extracts from 5-day NGF-differentiated PC12 cells treated for 24 h with
different concentrations of 2,5-HD. For the quantitation, the levels of α-tubulin PTMs were normalized firstly on the total amount of proteins loaded per lane, through
the Coomassie blue staining, and then on the total level of α-tubulin in the respective sample. The data are expressed as fold change with respect to control
(mean ± SEM). *p < 0.05 vs control (CTRL) according to one-way ANOVA, Fisher LSD post hoc test. (C) 2,5-HD alters the distribution of stable microtubules, the
ones characterized by the presence of detyrosinated and acetylated α-tubulin. NGF-differentiated PC12 cells were stained for tyrosinated (Tyr Tub, red), detyr-
osinated (deTyr Tub, green) and acetylated tubulin (Ac Tub, red) to investigate microtubule organization and acquired with a widefield fluorescence microscope. All
cells were also concurrently stained with DAPI (blue) to visualize the nuclei. Scale bar: 20 μm. (D) Percentage of NGF-differentiated PC12 cells presenting accu-
mulation of detyrosinated microtubules in perinuclear zone respect to the total number of differentiated cells. 2,5-HD significantly increased the percentage of cells
with the accumulation of stable microtubules (deTyr Tub) at each dose of treatment. All values are expressed as mean ± SEM. *p < 0.05 and **p < 0.001 vs CTRL
according to χ2 test, at least 770 cells for each group were analysed. (For interpretation of the references to colour in this figure legend, the reader is referred to the
web version of this article.)
Fig. 5. 2,5-Hexanedione alters microtubule stability in NGF-differentiated PC12 cells, but does not affect tubulin polymerization kinetics and microtubule ultra-
structure in vitro.
(A–B) Triton-X100-soluble (representing the α-tubulin dimer pool, D) and -insoluble fraction (α-tubulin incorporated into microtubules, M) of α-tubulin (α-tub) and
its tyrosinated form (Tyr Tub) in NGF-differentiated PC12 cells were analysed by (A) immunoblot and (B) densitometric analyses, shown as ratio. 2,5-HD influenced
the tubulin distribution between the two fractions. Interestingly, the ratio was shifted towards the free-tubulin fraction, at the highest dose of toxin, only for the
tyrosinated form of tubulin. All values are expressed as mean ± SEM. **p < 0.001 vs control (CTRL) of each group according to one-way ANOVA, Tukey HSD post
hoc test. (C) Representative kinetic curves of pure bovine brain tubulin (30 μM) polymerized in assembly buffer in the absence (CTRL) or presence of different
concentrations of 2,5-HD. Reactions were followed turbidimetrically at 350 nm for 90min at 37 °C. (D) Ultrastructure of microtubules assembled in absence or
presence of 2,5-HD in the same conditions described above for the kinetic curves. The microtubules assembled in vitro were fixed with 0.5% glutaraldehyde prior to
perform the negative staining with uranyl acetate. CTRL and 20mM 2,5-HD treated tubulin are shown: the ultrastructure of microtubules is not affected by 2,5-HD in
the tested conditions. Scale bar: 100 nm.
Table 1
Kinetic parameters of tubulin assembly in the presence of 2,5-hexanedione.
Kinetic parameters CTRL 0.2mM 2mM 20mM
P value 4.00 ± 0.25 4.22 ± 0.23 4.91 ± 0.45 4.77 ± 0.79
Vi 0.0067 ± 0.0017 0.0079 ± 0.0021 0.0057 ± 0.0037 0.0043 ± 0.0015
ΔA 0.221 ± 0.029 0.253 ± 0.036 0.196 ± 0.084 0.192 ± 0.035
The table reports the kinetic parameters calculated from the polymerization curves: the number of successive steps in the nucleation phase (P value), the maximal
velocity of polymerization at the very initial elongation phase (Vi, ΔA/min) and the total extent of microtubule assembly as the total absorbance variation (ΔA). All
values are expressed as mean ± SEM.
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were observed in the presence of 2,5-HD in our experimental condi-
tions. Accordingly, electron microscopy performed on these samples
revealed a conventional ultrastructure of MTs formed in the presence of
2,5-HD (Fig. 5D). Although 2,5-HD altered the in cell MT system,
causing the destabilization of dynamic MTs and the accumulation of
stable MTs in addition to the fragmentation of total α-tubulin, it was
not able to affect pure in vitro tubulin, meaning that the effects observed
in NGF-differentiated PC12 cells could be mediated also by other pro-
teins or that the reaction with the lysine residues needs some time to
occur.
3.5. Mice injected with 2,5-hexanedione show a decreased level of
tyrosinated tubulin in nigral dopaminergic neurons
Since early alterations in the MT system have already been observed
in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated
mice [49], we investigated α-tubulin PTM state also in C57BL mice
injected with 8mmol/Kg of 2,5-HD for 19 consecutive days following
the scheme already reported in the literature [30]. First of all, we had to
assess whether there was any sign of neurodegeneration with this ex-
perimental paradigm (Fig. 6). The parameters considered to unveil the
presence of neurodegeneration were: the number of dopaminergic
neurons in Substantia nigra pars compacta and the density of their
terminals projecting to the Corpus striatum, in particular to its dorsal
part. The stereological counts of TH-positive neurons in the pars com-
pacta revealed no loss of nigral dopaminergic neurons in toxin-treated
mice versus controls (Fig. 6B), as shown in the representative images of
midbrain coronal sections (Fig. 6A). Similarly, the im-
munohistochemical staining for TH and its densitometric analysis of
Corpus striatum did not show any significant change in dopaminergic
axonal terminals in total, dorsal and dorso-lateral striatum (Fig. 6C–D).
Although the selected 2,5-HD treatment was not able to induce the
death of nigral dopaminergic cells or the loss of their striatal projection,
we further investigated the composition of α-tubulin PTMs in three
different compartments of nigrostriatal TH-positive neurons (Fig. 7A):
the soma, the axons and their terminals. In order to analyse the various
α-tubulin PTMs in the dopaminergic structures, sagittal brain sections
were concurrently stained for TH and for tyrosinated (Fig. 7B–C), de-
tyrosinated or acetylated tubulin (Fig. S2). Images were acquired using
a confocal microscope and the fluorescence intensity of each α-tubulin
PTM was measured for all neuronal compartments in the corresponding
brain regions. This analysis highlighted the specific decrease of tyr-
osinated tubulin level in the soma of dopaminergic neurons in 2,5-HD-
injected mice versus controls (Fig. 7B–C). These results are consistent
with the shift of tyrosinated tubulin from polymerized to un-
polymerized pool we observed in NGF-differentiated PC12 cells after
2,5-HD treatment (Fig. 5A–B) and both of them imply the destabiliza-
tion of MTs.
3.6. 2,5-Hexanedione affects microtubule stability in human fibroblasts
from Parkinson's disease patients
Once a general picture of the impact of the 2,5-HD action on a
neuron-like cellular model and in mice had been achieved, we moved to
a human system. We chose to use human skin fibroblasts, since they are
considered as an easily available and robust PD experimental model
[59], and because we could take advantage of the expertise already
present in our lab in working with this kind of cells derived from PD
patients [60]. To this purpose, the effect of 2,5-HD was tested on skin
fibroblasts, obtained from healthy donors and patients harbouring
Fig. 6. 2,5-Hexanedione does not induce loss of dopaminergic neurons in Substantia nigra pars compacta nor the denervation of dopaminergic axonal terminals in
Corpus striatum.
Coronal sections of Substantia nigra pars compacta (A) and Corpus striatum (C) C57BL 15-month old mice injected with saline (CTRL, left) or with 8mmol/kg 2,5-HD
for 19 days (2,5-HD, right) used for quantitative analyses of TH immunohistochemical staining (B, D). (A) Representative images of Substantia nigra pars compacta
coronal sections used for the stereological counts of nigral TH-positive neurons. Scale bar: 100 μm. (B) Estimates of the total number of nigral TH-positive neurons in
both hemispheres from mice injected with saline (CTRL, n= 8) or with 2,5-HD (2,5-HD, n= 5) calculated by stereological counts on seven coronal sections per
animal throughout the Substantia nigra pars compacta. No differences among the groups were observed. All values are expressed as mean ± SEM. (C) Representative
images of Corpus striatum coronal sections used for the densitometric analyses of striatal TH-positive axonal terminals. Scale bar: 500 μm. (D) Densitometric analysis
of TH-positive axonal terminals in total, dorsal and dorso-lateral Corpus striatum of mice injected with saline (CTRL, n= 6) or with 2,5-HD (2,5-HD, n=5) was
performed on two coronal sections per animal measuring the optical density (O.D.). All values are expressed as mean ± SEM.
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mutations in PRKN (Table 2), a specific PD-related gene coding for
Parkin, an ubiquitin E3 ligase [61] also able to bind and stabilize MTs
[35,62]. At this point, we wanted to evaluate whether 2,5-HD could
have an effect on MT destabilization that has been previously described
in PD patient fibroblasts [60]. After 24 hour-exposure to 2,5-HD, we
observed that both cell viability and morphology were not affected by
the treatment (Fig. 8A–D). Nevertheless, in baseline conditions differ-
ences in fibroblasts from PD patients and healthy subjects were seen in
terms of morphology, since they were wider and larger (Fig. 8A), had a
larger cell area (Fig. 8C) and a significantly lower ratio between max-
imum and minimum axis (Fig. 8D), as shown by the present morpho-
metric analyses and according to our previous work [60].
To assess the effect of 2,5-HD on MT stability in human fibroblasts,
the state of tubulin polymerization was analysed as well. As previously
reported [60], we confirmed that MT destabilization was present in
patients already at baseline without the addition of any stressor, then
we observed that 2,5-HD treatment was able to induce stabilization of
MTs only in PD patient cells (Fig. 8E–F). Interestingly, MT stabilization
occurred already at the lowest dose of 2,5-HD in PD fibroblasts,
whereas healthy ones were not affected at all, suggesting greater MT
frailty in PD patient cells. These data show that 2,5-HD impacts MT
stability both in neuron-like cells and in human fibroblasts. It is note-
worthy that they also suggest that the genetic background may really
make a difference in terms of MT susceptibility to this environmental
PD toxin.
4. Discussion
In this work, we focused on MT cytoskeleton, since there is a
growing body of evidence supporting its dysfunction in the pathogen-
esis of several neurological diseases including PD [63–65]. Here, we
demonstrate for the first time that MT dysfunction occurs in 2,5-HD-
induced neurodegeneration, a finding that is consistent with the im-
pairment of MT stability and α-tubulin PTMs already found in MPTP-
intoxicated mice [49], in human skin fibroblasts derived from PD
patients [60] and even in mesenchymal stromal cells of patients with
Progressive Supranuclear Palsy [66], a rare neurodegenerative disorder
associated with both dementia and parkinsonism.
Several lines of evidence have shown that mitochondrial dysfunc-
tion is a key element in the pathogenesis of PD [67] and that is why
mitochondria have been in the spotlight of the scientific community for
many years. Recently, Qi and colleagues [68] exhaustively analysed the
effects of 2,5-HD on mitochondria-related pathways in undifferentiated
PC12 cells, showing that toxin-induced apoptosis occurs via mi-
tochondria-induced activity of Caspase-3. Moreover, all these 2,5-HD-
induced alterations were successfully prevented by treatment with the
anti-oxidant taurine [69]. Unfortunately, the authors did not look at
any components of the cytoskeleton in undifferentiated cells, so we
cannot really compare the respective role of mitochondria- and MT-
based effects in triggering cell death. Nevertheless, Malorni and col-
leagues [54] already demonstrated that 2,5-HD interferes with cell
proliferation, reporting that cells detached from the substrate when
they were in the mitotic phase after treatment. Accordingly, the toxin
induces significant mortality of undifferentiated PC12 cells [68],
whereas treating NGF-differentiated PC12 cells with comparable con-
centrations of 2,5-HD did not induce any significant cell death. This is a
clue supporting the direct action of 2,5-HD on MTs, since they are re-
sponsible for the assembly/disassembly of the mitotic spindle and
suggesting why cell viability was not affected in non-dividing cells, such
as neurons. Therefore, we analysed the neurotoxic action of 2,5-HD
more accurately in 5-day NGF-differentiated PC12 cells, since they are
an established neuronal model. In this model we reported that the
formation of varicosities along neurites were already evident at 2mM of
toxin and even more striking the increased number of differentiated
cells with perinuclear accumulation of stable MTs already at 0.2mM,
when the loss of cell viability, mitochondrial alterations and autophagy
activation were not yet detectable. This finding suggests that mi-
tochondria are unlikely to be the first target of 2,5-HD. A consistent
finding was that also healthy fibroblasts exposed to 2.8mM 2,5-HD
underwent changes in their morphology after 3 days of treatment,
showing a large swollen cell body and thin elongated processes [70]. In
fact, alterations in cell shape typically depend on the cytoskeleton and,
in particular, on MT functionality, with a possible block of the axonal
transport leading to accumulation of proteins and organelles.
Abnormal accumulations of NFs have been detected in many human
neurodegenerative disorders, including amyotrophic lateral sclerosis,
Alzheimer's disease, PD and Charcot-Marie-Tooth disease [71]. The
effects of 2,5-HD on intermediate filaments have been extensively de-
scribed in many previous studies, but MTs have been poorly in-
vestigated. By immunocytochemical approach, we highlighted the
presence of NF accumulation inside the axonal swellings and in the
perinuclear area in NGF-differentiated PC12 cells, a finding that is
consistent with data obtained in other cellular models [27,55,56,72]
and in patients showing distal axonal accumulation of NFs [73,74].
Meanwhile, we observed the significant reduction in NF levels by im-
munoblotting as seen also in rat dorsal root ganglia cells [31] and in the
nervous system of intoxicated rats [75,76]. Similarly, in NGF-differ-
entiated PC12 cells fluorescence staining highlighted a partial frag-
mentation of the MT network and, surprisingly, perinuclear
Fig. 7. Nigral dopaminergic neurons of mice injected with 2,5-hexanedione show a decreased level of tyrosinated tubulin.
(A) Overview of the nigrostriatal pathway in a sagittal section of mouse brain starting from the cell bodies of dopaminergic neurons in the Substantia nigra pars
compacta (1, SN), passing through the nigrostriatal fibers (2, NSF) and ending with their axonal terminals in the dorsal striatum (3, CS). The brain section was stained
for tyrosine hydroxylase (TH, green), marker of dopaminergic neurons, together with DAPI (grey) to visualize the nuclei. Scale bar: 500 μm. (B) Representative
confocal images and (C) fluorescence intensity analyses of different regions of dopaminergic neurons from three areas of nigrostriatal pathway in C57BL 15-month
old mice treated with saline (CTRL) or with 2,5-HD (8mmol/kg for 19 days, 2,5-HD): the neuronal bodies in Substantia nigra pars compacta (1), the nigrostriatal fibers
(2) and the axonal terminals in Corpus striatum (3). (B) The green signal represents the tyrosine hydroxylase (TH) staining, while the red signal is the tyrosinated
tubulin (Tyr Tub). Scale bar: 20 μm. (C) Quantification of fluorescence intensity of tyrosinated tubulin (Tyr Tub) in dopaminergic neurons in three different areas of
the nigrostriatal pathway in sagittal sections of mice treated with saline (CTRL, n= 8) or with 2,5-HD (2,5-HD, n= 7). Data are expressed in grey levels using dot
plots, with every dot representing the mean fluorescence intensity value per animal. *p < 0.05 vs control group (CTRL) according to Mann-Whitney U test. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Table 2
Phenotype and genotype characterization of investigated individuals.



















The characteristics present in the table are: the identification code; the geno-
type (just for PD patients); the sex; the age at time of skin biopsy and estab-
lishment of fibroblast cell line; the age at which the patient first noticed a PD-
related symptom (that was considered the age at onset of the disease).
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accumulation of stable MTs, just like NFs. To our knowledge, this MT
accumulation has never been observed before, probably because the
particular structure of dopaminergic neurons makes them particularly
susceptible to toxins that impact on MTs, whereas in other cell types
this effect could be masked and underestimated. On the other hand, the
MT fragmentation along the axons could be connected to the already
known action of some anti-cancer drugs, which exerted adverse effects
on the peripheral nervous system in clinical studies, with documenta-
tion of degeneration and fragmentation of sensory axons, reduced
axonal length and also reduced axonal transport in animal models [77].
Interestingly, it has recently been reported that intermediate filament
accumulation directly alters MT stability in motor neurons in Cae-
norhabditis elegans [78]. Kurup and colleagues showed for the first time
that the genetic loss or the pharmacological disruption of the essential
intermediate filament network was sufficient to shift the MT balance
from stable to dynamic, participating in the regulation of axonal
transport, from which synapse rewiring depends in C. elegans. Actually,
2,5-HD acts directly on both intermediate filaments and MTs, but to a
Fig. 8. 2,5-Hexanedione affects microtubule stability in human fibroblasts from Parkinson's disease patients.
(A) Representative phase contrast images of cultured human skin fibroblasts of healthy and PD-affected individuals treated for 24 h with different concentrations of
2,5-HD. Scale bar: 50 μm. (B) Cell viability, evaluated by MTT test, was not affected in both groups by the toxin. (C–D) Morphometric analyses showed an increased
area (C) and a significantly reduced ratio between maximum and minimum axis (D) in fibroblasts of patients harbouring mutations in PRKN gene. All values are
expressed as mean ± SEM. *p < 0.05 vs healthy fibroblast control group (CTRL) according to according to Mann-Whitney U test. (E–F) Triton-X100-soluble
(representing the α-tubulin dimer pool, Dim) and -insoluble fraction (α-tubulin incorporated into microtubules, MTs) of human skin fibroblasts were analysed by (E)
immunoblot and (F) densitometric analyses, shown as ratio between free dimers and microtubules. The genetic background influences the tubulin distribution
between the two fractions already at the baseline condition. The PD fibroblasts resulted much more susceptible to the action of 2,5-HD, in fact, the ratio was shifted
towards the microtubule fraction even at lower doses of toxin. All values are expressed as mean ± SEM. ‡p < 0.05 vs healthy control (CTRL) according to one-way
ANOVA, Fisher LSD post hoc test; *p < 0.05 and #p < 0.01 vs PD control group (CTRL) according to one-way ANOVA, Fisher LSD post hoc test.
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different extent, possibly due to the different intracellular amount of
the two types of filaments, since NFs account for up to 85% of the total
protein of fully differentiated neurons [79], making it difficult to define
the specific contribution of NFs and MTs to the final effect.
MTs show a dynamic behaviour, switching rapidly between growth
and depolymerisation phases, but there is a limited range of acceptable
MT dynamic behaviours in neurons, outside of which MTs cannot
function normally and the cells cannot survive [80]. Indeed, both re-
duced or increased MT stability can lead to neurodegeneration [77].
Since PTMs of tubulin have been correlated to stability of MT cytos-
keleton for a long time and are currently considered crucial regulators
of its functions, they have a strong potential to be implicated in a
number of disorders. For example, mice lacking tubulin-tyrosine ligase
activity show strongly upregulated levels of detyrosinated tubulin in the
brain and die perinatally due to massive defects in brain architecture
[81], while axonal transport defects have been linked to decreased
tubulin acetylation in various neurodegenerative diseases, including PD
[82]. Interestingly, we observed a specific imbalance of modified forms
of α-tubulin in NGF-differentiated PC12 cells after toxin exposure.
Worthy of note, all the three PTMs analysed were significantly affected
by 2,5-HD and changed in level, distribution or both. Here, we showed
different types of toxin effects on MT system. First, a MT stabilizing
effect suggested by the increased levels of detyrosinated tubulin, asso-
ciated to stable MTs, and its perinuclear accumulation together with the
decreased levels of tyrosinated tubulin, marker of native and dynamic
MT pool. Second, the analysis of tubulin polymerization in NGF-dif-
ferentiated PC12 cells revealed the imbalance of tyrosinated tubulin
ratio between dimers and MTs, showing that 2,5-HD caused the re-
duction in the dynamic MT fraction, suggesting MT destabilization. An
alteration in MT stability was also found in vivo in dopaminergic neu-
rons in Substantia nigra pars compacta of mice intoxicated with 2,5-HD.
Similarly, the amount of dynamic MTs was significantly reduced in the
soma of nigral dopaminergic neurons. Surprisingly, acetylated MTs
were affected by the treatment in terms of distribution, but their level
remained unchanged. Since acetylation is known to happen on lysine
40 of α-tubulin, making MTs more resistant to mechanical stress
[83,84], we can guess that also 2,5-HD may be able to interact with the
same free lysine residues competing for the binding. From this stand-
point, it is possible that in 2,5-HD models the acetylated MTs are not an
appropriate marker to analyse toxin effects inasmuch they could be
underestimated. In addition, 2,5-HD treatment was able to alter MT
stability also in human skin fibroblasts from PD patients harbouring
mutations in PRKN gene already at the lowest dose of toxin, but not in
the healthy ones, revealing how genetic background and environment
can interact in impacting MT system in pathological conditions. Con-
sistently with this, but even more strikingly, it has been shown that also
a particular mitochondrial DNA background can increase the sensitivity
to 2,5-HD toxicity, triggering the onset of Leber's hereditary optic
neuropathy (LHON) in cybrids and fibroblasts harbouring mutation in
LHON gene [85]. These data strongly suggest that the genetic back-
ground may really make a difference in MT susceptibility to environ-
mental factors, such as this PD toxin. Hence, the contribution of en-
vironmental toxins to the study of neurodegeneration diseases is
revaluated in terms of potential dissection of the various neurodegen-
erative pathways.
4.1. Conclusions
In conclusion, our data support the hypothesis that MT system im-
pairment is an early and crucial event in the 2,5-HD-induced neuro-
degeneration of the dopaminergic system, suggesting that MT dys-
function may have a key role in the process leading neurons to death.
Therefore, it could be a good target for new neuroprotective drugs. The
use of MT-stabilizing agents, such as epothilone D, holds promise in
animal models of neurodegeneration [49,86]. Unfortunately, a clinical
trial on patients with mild Alzheimer's disease was discontinued due to
the appearance of adverse side effects [87]. On the other hand, al-
teration of tubulin PTMs could be a risk factor and a new biomarker for
specific disorders, indicating reduced protection against potential dis-
ease-causing insults, such as 2,5-HD. Among the various enzymes re-
sponsible for the various modifications, HDAC6 inhibition is able to
rescue pathological phenotype in many different neurodegenerative
models [82,88,89], making it the most promising option for the treat-
ment of neurodegeneration, so much so that in 2018 a Phase I clinical
trial was started with the aim of evaluating the safety, tolerability and
pharmacokinetics of CKD-504 (a selective HDAC6 inhibitor) in Hun-
tington's disease patients [90]. Consequently, the modulation of tubulin
PTMs offers new hope for the treatment of neurodegenerative diseases,
including PD.
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